
    
      There are two parts to the study. A dose-escalation phase looking at three doses of
      RetinoStat starting with the lowest dose, three patients will be recruited at each dose
      level. The escalation phase will be followed by a dose confirmation phase where the highest
      dose that is safe and well tolerated will be examined in 9 patients.
    
  